Related references
Note: Only part of the references are listed.High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma
Gerard J. Chu et al.
HISTOPATHOLOGY (2023)
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy
Thomas Hager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Hedy L Kindler et al.
LANCET ONCOLOGY (2022)
Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers
Rossella Bruno et al.
DIAGNOSTICS (2022)
Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma
Chenglu He et al.
ONCOLOGY LETTERS (2021)
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
Soren Weidemann et al.
BIOMEDICINES (2021)
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer
Reiri Shimazaki et al.
CELLULAR ONCOLOGY (2021)
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma
Masayuki Watanabe et al.
SCIENTIFIC REPORTS (2021)
Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma
Fraser Brims
CANCERS (2021)
Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer
Danfang Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas
Sarita Prabhakaran et al.
HUMAN PATHOLOGY (2020)
Pathology of Malignant Pleural Mesothelioma
Yin P. Hung et al.
THORACIC SURGERY CLINICS (2020)
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer
Bruno Maerkl et al.
BMC CANCER (2019)
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma
Lucian R. Chirieac et al.
CANCER (2019)
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
Nicolas Alcala et al.
EBIOMEDICINE (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Aliya Noor Husain et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse
Zhixun Dou et al.
CELL METABOLISM (2018)
Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma Ten Years of Clinical Experience in Relation to International Guidelines
Anders Hjerpe et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival
Vivek Verma et al.
CLINICAL LUNG CANCER (2018)
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis
David B. Nelson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma
Baoqing Tian et al.
ONCOTARGET (2017)
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
Shingo Inaguma et al.
ONCOTARGET (2017)
The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis
Daniel Brungs et al.
ONCOTARGET (2017)
PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer
Xian Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Prognostic value of p21-activated kinase 4 in resected pancreatic cancer
Sehhoon Park et al.
APMIS (2017)
Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma
Yusuke Takayama et al.
CANCER RESEARCH (2016)
NCCN Guidelines® Insights Malignant Pleural Mesothelioma, Version 3.2016 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
Tumoral CD10 Expression Correlates with Aggressive Histology and Prognosis in Patients with Malignant Pleural Mesothelioma
Kyuichi Kadota et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion
Songwang Cai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration
Bao Song et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients
Danni Li et al.
TUMOR BIOLOGY (2015)
p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma
Weisi Liu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis
Sebastien Tabaries et al.
ONCOTARGET (2015)
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data
Giulia Pasello et al.
ONCOTARGET (2015)
Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study
L. Capkova et al.
NEOPLASMA (2014)
Mesothelioma with signet-ring cell features: report of 23 cases
Nelson G. Ordonez
MODERN PATHOLOGY (2013)
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysis
Roy Sidi et al.
EUROPEAN JOURNAL OF CANCER (2011)
Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
Helmut P. Sandeck et al.
DIAGNOSTIC PATHOLOGY (2010)
Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter
Ke Tan et al.
HUMAN PATHOLOGY (2010)
Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases
Sonja Klebe et al.
MODERN PATHOLOGY (2010)
Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma
Asma Begum et al.
CANCER SCIENCE (2009)